ChiCTR1800014553.
Study name | Comparative study of nasal high‐flow oxygen therapy and noninvasive positive pressure ventilation for moderate AECOPD: randomized open non‐inferiority trial |
Methods | RCT, parallel‐group design |
Participants | Total number of participants: 86 Setting: China Inclusion criteria: AECOPD; blood gas analysis pH 7.25‐7.35, PaCO2 > 50 mmHg Exclusion criteria: age < 18; no informed consent obtained; severe respiratory failure requiring tracheal intubation; NPPV contraindications; patients with short‐term prognosis; other organ failure; tracheotomy |
Interventions | Intervention group (HFNC) Control group (NPPV) |
Outcomes | All outcomes measured: arterial blood gas, respiratory rate, blood pressure, daily treatment time; parameter setting of NPPV and HFNC; change and time of respiratory support; intubation; time to intubation; dyspnoea score; comfort score; facial skin breakage; number of daily nursing interventions; respiratory and extrapulmonary complications; ICU length of stay; hospital length of stay; discharge outcome (death, improved) Outcomes relevant to this review: arterial blood gas, respiratory rate, intubation; dyspnoea score; comfort score; respiratory and extrapulmonary complications; ICU length of stay; hospital length of stay; mortality |
Starting date | 21 January 2018 |
Contact information | Dingyu Tan, 32494845@qq.com. Bingyu Ling |
Notes |